F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the Facility failed to properly store and label
medications and dispose of expired medications for 4 of 4 residents (R25, R59, R63, R283) reviewed for
medication storage and labeling in the sample of 46.
Findings include:
On 9/26/24 at 9:15 AM, the medication cart on the B Hall was inspected with V12, Registered Nurse (RN).
The medication cart contained the following:
1-R63's Humalog Quickpen labeled 8/24 in black marker. V12, RN, stated insulin pens are dated upon
opening and are usually thrown out after 30 days.
2-R63's unopened vial of Epogen with packing instructions documenting, Refrigerate.
3-One half of a white circular tab in a medicine cup that was not labeled or dated. V12, RN, stated, That is
magnesium for R59. She gets half a tab in the morning and the other half in the afternoon.
4- One opened carton of thickened lemon water labeled 5/20 in black marker. V12, RN, stated that will be
thrown away.
On 9/26/24 at 9:22 AM, the medication cart on the F hall was inspected with V10, RN. The medication cart
contained the following:
5-R25's sealed, unopened Latanoprost Opthalmic Solution 0.005% eye drops with the packing instructions,
Refrigerate Unopened.
6-R25's Tresiba FlexTouch Solution Pen-Injector 100 unit/milliliter dated 8/24/24 in black marker.
7-One opened Humalog pen dated 8/1/24 in black marker that was not labeled with any resident's name.
8-One opened Novolog Kwikpen dated 3/14/24 in black marker that was not labeled with any resident's
name. V10, RN, stated she does not know who the insulin pens belong to, because night shift gives the
morning insulin.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 6
Event ID:
145508
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145508
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland Health Care Center
1450 26th Street
Highland, IL 62249
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
9-One bottle of Pro-Heal that was opened, but was not dated upon opening. The bottle documented
manufacturer's instructions to discard the product 60 days after opening.
Level of Harm - Minimal harm
or potential for actual harm
10-One bottle of Multivitamin Senior Tabs with the manufacturer label, Best by 1/2024.
Residents Affected - Some
11-One bottle of 500 milligram (mg) calcium citrate tablets with the manufacturer label, Best by 6/2024.
12-One bottle of 650 mg sodium bicarbonate tablets with the manufacturer label, Best by 6/2024.
On 9/26/24 at 3:43 PM, V2, Director of Nursing (DON), stated insulin pens should be labeled with resident
names, dated upon opening, and discarded within 30 days of opening. She stated expired items should be
thrown away, and manufacturer's instructions for medication storage should be followed.
The Facility's Medication Storage Policy revised 8/23/22 documents, This facility stores all drugs and
biologicals in a safe, secure, and orderly manner and in accordance with state and federal regulations. The
nursing staff is responsible for maintaining medication storage and preparation areas in a clean, safe, and
sanitary manner. Drug containers that have missing, incomplete, improper, or incorrect labels shall be
returned to the pharmacy for proper labeling before storing. Discontinued, outdated, or deteriorated drugs
or biologicals shall be returned to the dispensing pharmacy or destroyed. Medications shall be administered
prior to the manufacturer's expiration date. Medications requiring refrigeration are stored in a refrigerator
located in the drug room at the nurses' station or other secured location.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145508
If continuation sheet
Page 2 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145508
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland Health Care Center
1450 26th Street
Highland, IL 62249
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Implement a program that monitors antibiotic use.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review the facility failed to maintain a system of unnecessary or inappropriate
antibiotic use for 4 out of 4 residents (R16, R28, R45, R48) investigated for antibiotic use in a sample of 36.
Residents Affected - Some
Finding include:
1. R16's EMR (Electronic Medical Records) dated 11/14/23 documents that resident was admitted to the
facility.
R16's EMR dated 11/14/23 documents diagnose of Chronic Kidney Disease, Stage 4 (Severe),
Neuromuscular Dysfunction of Bladder, Unspecified, and END STAGE RENAL DISEASE.
R16's Care Plan dated 02/29/24 documents (R16) has end stage renal failure r/t (related to) End stage
disease.
R16's MDS (Minimum Data Set) dated 08/07/24 documents a BIMS (Brief Interview for Mental Status)
score is 14. The MDS documents that the resident requires substantial/maximal assistance with toilet
hygiene. The MDS documents that the resident is always incontinent of bladder and bowel.
R16's Nursing Note dated 07/20/24 at 5:23 PM documents Wife and resident aware of positive uti and
beginning Cipro. Resident continuously pulls off oxygen and it needs to be replaced. Wife states resident
did this frequently at hospital previously when wearing 02. Frequent monitoring of resident this shift to
ensure 02 is attached to machine and in resident nose.
R16's Physician Order dated 07/20/24 documents Cipro Tablet 500 MG (Ciprofloxacin HCl); Give 1 tablet by
mouth every 12 hours for UTI.
R16's Urine Bacteria Culture dated 07/17/24 documents Streptococci, Beta Hemolytic Group B. There is
not a susceptibility report associated with this report to show which antibiotics are resistant or susceptible
to the bacteria.
R16's MAR (Medication Administration Record) dated July 2024 documents that resident received 7 doses
of Ciprofloxacin HCl.
2. R25's EMR dated 11/01/21 documents that the resident was admitted to the facility.
R25's EMR dated 12/04/20 documents a diagnose of Benign Prostatic Hyperplasia with lower urinary tract
symptoms and Overactive Bladder.
R25's EMR dated 01/14/23 documents a diagnose of Chronic Kidney Disease, Stage 4 (Severe).
R25's Care Plan dated 12/09/20 documents Impaired urinary elimination R/T obstruction of urethra R/T
BPH.
R25's MDS dated [DATE] documents a BIMS score of 4. The MDS documents that the resident requires
substantial/maximal assistance with toilet hygiene. The MDS documents that the resident is always
incontinent of bladder and bowel.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145508
If continuation sheet
Page 3 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145508
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland Health Care Center
1450 26th Street
Highland, IL 62249
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
R25's Nursing Note dated 06/14/24 documents UA with C and S results faxed to MD. Per MD resident has
UTI and to start ABX Cipro 500 mg PO BID x 10 days. POA notified of UTI and ABX and aware. Order
placed and sent to pharmacy. Will continue to monitor.
R25's Physician Order dated 06/14/24 documents Ciprofloxacin HCl 500 MG Tablet; GIVE 500 MG BY
MOUTH TWO TIMES A DAY FOR UTI FOR 10 DAYS.
R25's MAR dated June 2024 documents that the resident received 19 doses of Ciprofloxacin.
R25's Urine Bacteria Culture dated 06/10/24 documents Streptococci, beta hemolytic group B.
There is not a susceptibility report associated with this report to show which antibiotics are resistant or
susceptible to the bacteria.
3. R45's EMR dated 08/24/21 documents that the resident was admitted to the facility.
R45's EMR dated 08/24/21 documents Dementia in other diseases classified elsewhere, unspecified
severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety.
R45's Care Plan dated 06/19/24 documents (R45) has a Urinary Tract Infection.
R45's MDS dated [DATE] documents a BIMS score of 3. The MDS documents that the resident requires
substantial/maximal assistance for toilet hygiene. The MDS documents that the resident is always
incontinent of bladder and frequently incontinent of bowel.
R45's Nursing Note dated 06/18/24 at 8:59 PM documents New orders received for cephalexin 500mg x 7
days. Awaiting culture.
R45's Physician Order dated 06/18/24 documents Cephalexin 500 MG Capsule; Give 1 tablet by mouth
every 8 hours for ABT for UTI for 7 Days.
R45's MAR dated June 2024 documents that the resident received 20 doses of Cephalexin.
R45's Urine Bacteria Culture dated 06/14/24 does not documents a bacteria specimen and susceptibility
report.
4. R48's EMR dated 02/21/22 documents that resident was admitted to the facility.
R48's EMR dated 11/11/21 documents a diagnosis of Chronic Kidney Disease, Unspecified.
R48's Care plan dated 12/06/23 documents (R48) has renal insufficiency r/t CKD (chronic kidney disease),
acquired absence of kidney.
R48's MDS dated [DATE] documents a BIMS score of 4. The MDS documents that the resident is
independent. The MDS documents that the resident is occasionally incontinent of bladder and always
incontinent of bowel.
R48's Nursing Note dated 09/18/24 at 7:23 PM documents resident returning to facility per family member.
Dx: bladder infection. N.O fluconazole 150mg 1 dose. Bactrim DS. take 1 tab BID x 5 days.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145508
If continuation sheet
Page 4 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145508
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland Health Care Center
1450 26th Street
Highland, IL 62249
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
family aware.
Level of Harm - Minimal harm
or potential for actual harm
R48's Physician Order dated 09/19/24 documents Bactrim DS Oral Tablet 800-160 MG
(Sulfamethoxazole-Trimethoprim); Give 1 tablet by mouth two times a day for UTI for 5 Days.
Residents Affected - Some
R48's MAR dated September 2024 documents that resident received 10 doses of Bactrim.
R48's Urine Bacteria Culture dated 09/18/24 document Escherichia Coli. The susceptibility report
documents that Bactrim is resistant to E. Coli.
On 09/26/24 at 2:50 PM, V2, DON (Director of Nursing) stated that she has hard time getting the doctor to
stop prescribing antibiotics before the cultures come back.
Facility policy Antibiotic Stewardship Policy/Procedure dated 12/13/23 documents It is the policy of this
facility to maintain an Antibiotic Stewardship Program (ASP) with the mission of promoting the appropriate
use of antibiotics to treat infections and reduce possible adverse events associated with antibiotic use.
Components of this policy were developed by using evidence-based practice guidelines and are aligned
with the Core Elements of Antibiotic Stewardship for Nursing homes, published by Centers for Disease
Control and Prevention (CDC) (1), and the State Operations Manual (Appendix PP): Guidance to Surveyors
of Long Term Care Facilities, published by CMS (2).
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145508
If continuation sheet
Page 5 of 6
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145508
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland Health Care Center
1450 26th Street
Highland, IL 62249
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
Provide rooms that are at least 80 square feet per resident in multiple rooms and 100 square feet for single
resident rooms.
Based on observation, interview and record review, the Facility failed to provide at least 80 square feet per
resident bed in multiple resident bedrooms for 13 of 80 residents (R9, R35, R41, R50, R51, R54, R63, R70,
R77, R133, R134, and R183) .
Findings include:
1.
Seven resident bedrooms provide 77.1 square feet per resident bed. Each of these seven rooms measure
15 feet 2 inches by 10 feet 2 inches. These rooms are two-bed rooms, and all are certified for
Medicaid/Medicare. These rooms are as follows: 105, 106, 107, 117, 118, and 119.
This was verified during room measurements.
2.
Three resident bedrooms provide 74 square feet per resident bed. These rooms measure 15 feet 3 inches
by 21 feet, with wardrobes measuring 23 inches by 63 and 24 inches by 94 inches. These rooms are all
certified for Medicaid/Medicare. These rooms are as follows: 225, 227, and 228.
On 9/26/24 at 9:10 AM V2, Director of Nursing (DON) stated the facility pays attention to the room size and
the residents' bed size when determining what room to place a resident in on admission. She stated they
make sure it is a safe environment for the residents and is able to be kept free of clutter.
Throughout the survey, there were no complaints from the residents who reside in the undersized rooms
regarding room size. There were no infection control concerns related to room size.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145508
If continuation sheet
Page 6 of 6